Related Experiment Videos
Expression and characterization of human group V phospholipase A2
1Department of Chemistry and Biochemistry, School of Medicine and Revelle College, University of California, San Diego, La Jolla, CA 92093-0601, USA.
Biochimica Et Biophysica Acta
|October 10, 1998
Summary
This study reports the over-expression and characterization of Group V phospholipase A2 (GV-PLA2), revealing its biochemical properties and substrate preferences. The findings clarify the enzyme's role in cellular processes and inflammation.
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- Group V phospholipase A2 (GV-PLA2) is implicated in cellular signaling and inflammation.
- Physical and biochemical properties of GV-PLA2 remain unclear from prior cellular studies.
Purpose of the Study:
- To over-express and characterize the physical and biochemical properties of GV-PLA2.
- To elucidate the enzyme's substrate specificity and optimal activity conditions.
Main Methods:
- Synthesized GV-PLA2 cDNA from human heart mRNA via RT-PCR.
- Expressed GV-PLA2 in E. coli, followed by single-step nickel affinity purification.
- Characterized enzyme activity, pH optimum, Ca2+ dependency, and substrate preference.
Main Results:
- Purified recombinant GV-PLA2 demonstrated Ca2+ dependency and optimal activity at pH 8.5.
- GV-PLA2 preferentially hydrolyzed phosphatidylethanolamine (PE) vesicles over phosphatidylcholine (PC) vesicles.
- The inhibitor LY311727 potently inhibited GV-PLA2 (IC50 ≈ 36 nM), similar to its effect on Group IIA PLA2.
Conclusions:
- The study successfully over-expressed and purified active GV-PLA2.
- Biochemical characterization revealed specific substrate preferences and optimal conditions for GV-PLA2 activity.
- GV-PLA2 inhibition by LY311727 suggests potential therapeutic targets in inflammatory pathways.